000			02289 a2200673 4500
005			20250516212409.0
264		0	_c20150420
008			201504s 0 0 eng d
022			_a2211-1247
024	7		_a10.1016/j.celrep.2014.04.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aPirazzoli, Valentina
245	0	0	_aAcquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. _h[electronic resource]
260			_bCell reports _cMay 2014
300			_a999-1008 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdenocarcinoma of Lung
650	0	4	_aAfatinib
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCetuximab
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aErbB Receptors _xgenetics
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMechanistic Target of Rapamycin Complex 1
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMice, Transgenic
650	0	4	_aMultiprotein Complexes _xmetabolism
650	0	4	_aMutation
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aRandom Allocation
650	0	4	_aTOR Serine-Threonine Kinases _xmetabolism
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aNebhan, Caroline
700	1		_aSong, Xiaoling
700	1		_aWurtz, Anna
700	1		_aWalther, Zenta
700	1		_aCai, Guoping
700	1		_aZhao, Zhongming
700	1		_aJia, Peilin
700	1		_ade Stanchina, Elisa
700	1		_aShapiro, Erik M
700	1		_aGale, Molly
700	1		_aYin, Ruonan
700	1		_aHorn, Leora
700	1		_aCarbone, David P
700	1		_aStephens, Philip J
700	1		_aMiller, Vincent
700	1		_aGettinger, Scott
700	1		_aPao, William
700	1		_aPoliti, Katerina
773	0		_tCell reports _gvol. 7 _gno. 4 _gp. 999-1008
856	4	0	_uhttps://doi.org/10.1016/j.celrep.2014.04.014 _zAvailable from publisher's website
999			_c23812029 _d23812029